Cozad Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-880
| Closed | -$162K | – | 360 |
|
|
2021
Q2 | $162K | Sell |
880
-8,115
| -90% | -$1.49M | 0.03% | 338 |
|
|
2021
Q1 | $1.38M | Sell |
8,995
-705
| -7% | -$108K | 0.22% | 118 |
|
|
2020
Q4 | $1.52M | Sell |
9,700
-1,765
| -15% | -$276K | 0.27% | 105 |
|
|
2020
Q3 | $1.31M | Sell |
11,465
-14,260
| -55% | -$1.63M | 0.25% | 111 |
|
|
2020
Q2 | $2.89M | Buy |
25,725
+1,400
| +6% | +$157K | 0.59% | 48 |
|
|
2020
Q1 | $2.18M | Buy |
24,325
+2,780
| +13% | +$250K | 0.76% | 37 |
|
|
2019
Q4 | $2.33M | Buy |
21,545
+11,840
| +122% | +$1.28M | 0.62% | 49 |
|
|
2019
Q3 | $951K | Buy |
+9,705
| New | +$951K | 0.27% | 107 |
|